Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 1 Jun 2007 |
| Report Pursuant to Section 28a of the Danish Securities Trading Act | 31 May 2007 |
| Genmab's HuMax-HepC Prevents Hepatitis C Virus Infection in Animal Model | 21 May 2007 |
| Genmab Attends Two May Investor Conferences | 14 May 2007 |
| Articles of Association dated April 19, 2007 (II) | 10 May 2007 |